Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
While CagriSema is a highly anticipated injectable, researchers are also fast-tracking other delivery methods
Image Credit: Alones / Shutterstock In a recent proof-of-concept study published in the journal eClinicalMedicine , researchers in Denmark describe the safety and efficacy outcomes of the first human trial of Dapiglutide, a novel drug that targets both the glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) receptors
Impact on NAION A paper published in 2024 in JAMA Ophthalmology created shock waves in the ophthalmic community by showing that subcutaneous semaglutide was associated with a significantly higher risk of developing nonarteritic anterior ischemic optic neuropathy (NAION)
Key Takeaways Frequently Asked Questions Not necessarily but the risk is real and significant without active countermeasures
Losing 5 to10 percent or more of body weight can help some women who arent ovulating regularly achieve normal cycles and ovulation, he says
I just replaced his before a vacation (one too many drops and dings), and naturally, we left it behind days later
